Search by Drug Name or NDC

NDC 65162-0240-03 Exemestane 25 mg/1 Details

Exemestane 25 mg/1

Exemestane is a ORAL TABLET, FILM COATED in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Amneal Pharmaceuticals LLC. The primary component is EXEMESTANE.

MedlinePlus Drug Summary

Exemestane is used to treat early breast cancer in women who have experienced menopause ('change of life'; end of monthly menstrual periods) and who have already been treated with a medication called tamoxifen (Nolvadex) for 2 to 3 years. This medication is also used to treat breast cancer in women who have experienced menopause whose breast cancer has worsened while they were taking tamoxifen. Exemestane is in a class of medications called aromatase inhibitors. It works by decreasing the amount of estrogen produced by the body. This can slow or stop the growth of some breast tumors that need estrogen to grow.

Related Packages: 65162-0240-03
Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Exemestane

Product Information

NDC	65162-0240
Product ID	65162-240_238703c3-9c6b-4d37-ac30-2afbc383ca74
Associated GPIs
GCN Sequence Number	n/a
GCN Sequence Number Description	n/a
HIC3	n/a
HIC3 Description	n/a
GCN	n/a
HICL Sequence Number	n/a
HICL Sequence Number Description	n/a
Brand/Generic	n/a
Proprietary Name	Exemestane
Proprietary Name Suffix	n/a
Non-Proprietary Name	Exemestane
Product Type	HUMAN PRESCRIPTION DRUG
Dosage Form	TABLET, FILM COATED
Route	ORAL
Active Ingredient Strength	25
Active Ingredient Units	mg/1
Substance Name	EXEMESTANE
Labeler Name	Amneal Pharmaceuticals LLC
Pharmaceutical Class	Aromatase Inhibitor [EPC], Aromatase Inhibitors [MoA]
DEA Schedule	n/a
Marketing Category	ANDA
Application Number	ANDA206421
Listing Certified Through	2024-12-31

Package

NDC 65162-0240-03 (65162024003)

Pricing Information	N/A
NDC Package Code	65162-240-03
Billing NDC	65162024003
Package	30 TABLET, FILM COATED in 1 BOTTLE (65162-240-03)
Marketing Start Date	2018-12-29
NDC Exclude Flag	N